Alzamend Neuro, Inc. (ALZN)
NASDAQ: ALZN · Real-Time Price · USD
0.9569
-0.1031 (-9.73%)
Mar 31, 2025, 2:31 PM EDT - Market open
Alzamend Neuro Market Cap
Alzamend Neuro has a market cap or net worth of $6.31 million as of March 31, 2025. Its market cap has decreased by -9.16% in one year.
Market Cap
6.31M
Enterprise Value
3.64M
1-Year Change
-9.16%
Ranking
Category
Stock Price
$0.96
Market Cap Chart
Since the IPO on June 15, 2021, Alzamend Neuro's market cap has decreased from $1.15B to $6.31M, a decrease of -99.45%. That is a compound annual growth rate of -74.69%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 28, 2025 | 6.99M | 10.97% |
| Dec 31, 2024 | 6.30M | -0.56% |
| Dec 29, 2023 | 6.34M | -88.37% |
| Dec 30, 2022 | 54.47M | -67.73% |
| Dec 31, 2021 | 168.82M | -85.28% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 738.61B |
| UnitedHealth Group | 472.03B |
| Johnson & Johnson | 394.52B |
| AbbVie | 363.15B |
| Novo Nordisk | 305.46B |
| AstraZeneca | 229.16B |
| Abbott Laboratories | 226.88B |
| Merck & Co. | 225.40B |